Matthew N Cooper Selected Research

Matthew N Cooper Research Topics

5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2018 - 11/2011
2	Insulin Resistance 01/2012 - 02/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 02/2010
1	Cough 05/2023
1	Autistic Disorder (Autism) 01/2023
1	Dysbiosis 09/2021
1	Medulloblastoma 01/2021
1	Neoplasms (Cancer) 01/2021
1	Photophobia (Light Sensitivity) 01/2021
1	Multiple Sclerosis 01/2020
1	Croup 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Autism Spectrum Disorder 09/2017
1	Hypoglycemia (Reactive Hypoglycemia) 03/2016
1	Fatigue 10/2015
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2013
1	Thrombosis (Thrombus) 02/2011
1	Ischemic Stroke 02/2011
1	Stroke (Strokes) 02/2011
1	Atherosclerotic Plaque (Atheroma) 02/2011
1	Rupture 02/2011
1	Macular Degeneration (Age-Related Maculopathy) 10/2009

3	Insulin (Novolin)FDA Link 12/2018 - 02/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 09/2021
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 02/2010
2	C-Reactive ProteinIBA 10/2015 - 10/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2019
1	SteroidsIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Complement System Proteins (Complement)IBA 09/2017
1	CarbohydratesIBA 03/2016
1	Hormones (Hormone)IBA 01/2012
1	AdiponectinIBA 01/2012
1	CollagenIBA 02/2011
1	EnzymesIBA 02/2011
1	ORALIT (ORS)IBA 02/2011
1	ImmunosorbentsIBA 02/2011
1	Glycoproteins (Glycoprotein)IBA 02/2011
1	Complement Factor H (Factor H)IBA 10/2009
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2009

5	Therapeutics 01/2023 - 10/2013
1	Drug Therapy (Chemotherapy) 01/2021
1	Phototherapy (Light Therapy) 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Glycemic Control 11/2011
1	Photochemotherapy (Photodynamic Therapy) 10/2009